STOCK TITAN

Canopy Growth Corp SEC Filings

CGC NASDAQ

Welcome to our dedicated page for Canopy Growth SEC filings (Ticker: CGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Canopy Growth Corporation (CGC) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, along with AI-powered summaries that help interpret complex documents. As a Canadian issuer with common shares listed on the Nasdaq Global Select Market, Canopy Growth files annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and proxy materials with the U.S. Securities and Exchange Commission.

Current reports on Form 8-K are central to understanding material events affecting CGC stock. Recent 8-K filings describe items such as the arrangement agreement to acquire MTL Cannabis Corp., including consideration structure, conditions, and termination provisions; term loan amendments and prepayment agreements; at-the-market equity distribution arrangements; quarterly earnings releases furnished under Item 2.02; and changes in executive leadership, including the appointment of the Chief Financial Officer. Other 8-Ks report on shareholder meeting results, including director elections, auditor re-appointment, share consolidation authority, and advisory say-on-pay votes.

Periodic reports—the Form 10-K and Form 10-Q—contain detailed financial statements, segment information for cannabis and Storz & Bickel, risk factors related to the cannabis industry and regulatory environment, management’s discussion and analysis, and disclosures on liquidity, capital resources, and internal controls. These filings also incorporate risk discussions referenced in the company’s news releases, including legal and regulatory risks in Canada, Europe, Australia, and the United States.

Proxy statements on Schedule 14A outline Canopy Growth’s corporate governance framework, board composition, committee structures, and executive compensation programs. They describe director nominees, voting matters presented at the annual general and special meeting, and updates to governance policies such as the code of business conduct and ethics, disclosure policy, and insider trading policy.

On this page, Stock Titan’s tools surface new CGC filings as they appear on EDGAR and generate AI summaries that highlight key terms, covenants, and implications for shareholders. Users can quickly see the main points of a lengthy 10-K, review the core provisions of financing or acquisition agreements disclosed in 8-Ks, and identify how shareholder votes and governance changes may affect the company. Filings related to insider compensation and board decisions are also accessible through these documents.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Canopy Growth (CGC)?

The current stock price of Canopy Growth (CGC) is $1.07 as of March 17, 2026.

What is the market cap of Canopy Growth (CGC)?

The market cap of Canopy Growth (CGC) is approximately 385.4M.

CGC Rankings

CGC Stock Data

385.42M
377.25M
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
SMITH FALLS

CGC RSS Feed